A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A
Clinical trial NCT03061201 · COMPLETED
Trial details
- NCT number
- NCT03061201
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2024-07-16
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.